Publications by authors named "Vidal Fey"

Claim this Profile
C
Comprehensive Genomic Profiling in Advanced Non-Small Cell Lung Cancer: A Real-World Cohort Study in Finland.
Kirsi Hormalainen, Kaisa Marttila, Matti Nykter, Toomas Uibu, Jarkko Ahvonen, Vidal Fey

Cancer Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXL-TBK1 driven AKT3 activation promotes metastasis.
Emily N Arner, Dina Alzhanova, Jill M Westcott, Stefan Hinz, Crina Elena Tiron, Vidal Fey

Sci Signal· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare Germline Variants in DNA Repair Genes Detected in -Negative Finnish Patients with Early-Onset Breast Cancer.
Viivi Kurkilahti, Venkat Subramaniam Rathinakannan, Erja Nynäs, Neha Goel, Kristiina Aittomäki, Vidal Fey

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Previously reported CCDC26 risk variant and novel germline variants in GALNT13, AR, and MYO10 associated with familial glioma in Finland.
Riikka Nurminen, Ebrahim Afyounian, Niina Paunu, Riku Katainen, Mari Isomäki, Vidal Fey

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kuura-An automated workflow for analyzing WES and WGS data.
Dhanaprakash Jambulingam, Venkat Subramaniam Rathinakannan, Samuel Heron, Johanna Schleutker, Vidal Fey

PLoS One· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression.
Lan Yu, Mervi Toriseva, Syeda Afshan, Mario Cangiano, Vidal Fey

Cancers (Basel)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A relational database to identify differentially expressed genes in the endometrium and endometriosis lesions.
Michael Gabriel, Vidal Fey, Taija Heinosalo, Prem Adhikari, Kalle Rytkönen

Sci Data· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ANO7 is associated with aggressive prostate cancer.
Elina Kaikkonen, Tommi Rantapero, Qin Zhang, Pekka Taimen, Virpi Laitinen, Vidal Fey

Int J Cancer· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying the druggable interactome of EWS-FLI1 reveals MCL-1 dependent differential sensitivities of Ewing sarcoma cells to apoptosis inducers.
Kalliopi Tsafou, Anna Maria Katschnig, Branka Radic-Sarikas, Cornelia Noëlle Mutz, Kristiina Iljin, Vidal Fey

Oncotarget· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aging and serum exomiR content in women-effects of estrogenic hormone replacement therapy.
Reeta Kangas, Timo Törmäkangas, Vidal Fey, Juha Pursiheimo, Ilkka Miinalainen

Sci Rep· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
Tao He, Didier Surdez, Juha K Rantala, Saija Haapa-Paananen, Jozef Ban, Vidal Fey

Gene· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wnt signalling is a bi-directional vulnerability of cancer cells.
David J Duffy, Aleksandar Krstic, Thomas Schwarzl, Melinda Halasz, Kristiina Iljin, Dirk Fey, Vidal Fey

Oncotarget· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimized design and analysis of preclinical intervention studies in vivo.
Teemu D Laajala, Mikael Jumppanen, Riikka Huhtaniemi, Vidal Fey, Amanpreet Kaur

Sci Rep· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A loss-of-function genetic screening identifies novel mediators of thyroid cancer cell viability.
Maria Carmela Cantisani, Alessia Parascandolo, Merja Perälä, Chiara Allocca, Vidal Fey

Oncotarget· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.
Kirsi Ketola, Miro Viitala, Pekka Kohonen, Vidal Fey, Zoran Culig

J Mol Biochem· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma.
David J Duffy, Aleksandar Krstic, Melinda Halasz, Thomas Schwarzl, Dirk Fey, Vidal Fey

Oncotarget· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput 3D screening reveals differences in drug sensitivities between culture models of JIMT1 breast cancer cells.
Vesa Hongisto, Sandra Jernström, Vidal Fey, John-Patrick Mpindi, Kristine Kleivi Sahlberg

PLoS One· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer.
Paula Vainio, John-Patrick Mpindi, Pekka Kohonen, Vidal Fey, Tuomas Mirtti

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells.
Sirkku Pollari, Suvi-Katri Leivonen, Merja Perälä, Vidal Fey, Sanna-Maria Käkönen

PLoS One· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.
Paula Vainio, Santosh Gupta, Kirsi Ketola, Tuomas Mirtti, John-Patrick Mpindi, Vidal Fey

Am J Pathol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monensin is a potent inducer of oxidative stress and inhibitor of androgen signaling leading to apoptosis in prostate cancer cells.
Kirsi Ketola, Paula Vainio, Vidal Fey, Olli Kallioniemi, Kristiina Iljin

Mol Cancer Ther· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Power training and postmenopausal hormone therapy affect transcriptional control of specific co-regulated gene clusters in skeletal muscle.
Eija Pöllänen, Vidal Fey, Timo Törmäkangas, Paula H A Ronkainen, Dennis R Taaffe

Age (Dordr)· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth.
Kristiina Iljin, Kirsi Ketola, Paula Vainio, Pasi Halonen, Pekka Kohonen, Vidal Fey

Clin Cancer Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors.
Jutta Huvila, Annika Brandt, Clarissa Rios Rojas, Salla Pasanen, Lauri Talve, Vidal Fey

Int J Gynecol Cancer· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of phosphorylation in redox regulation of photosynthesis genes psaA and psbA during photosynthetic acclimation of mustard.
Sebastian Steiner, Lars Dietzel, Yvonne Schröter, Vidal Fey, Raik Wagner

Mol Plant· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis